Recursion and Bayer expand Fibrosis collaboration to include inferential search capabilities
Salt Lake City - Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development, and be…
